Intern, Antibody Discovery & Lead Optimization

Genmab; Utrecht; On-site; EUR 7,600 - 9,100; Full time

Benefits offered by this job

Pension

Health insurance

Wellness benefits

Paid time off

Employee support programs

Job summary

Genmab is seeking an Intern for the Antibody Discovery and Lead Optimization team in Utrecht, Netherlands. You will gain hands-on experience across disciplines, focusing on establishing in vitro display technologies for antibody screening from large libraries.

This internship provides practical experience in molecular biology, protein engineering, and antibody discovery, boosting your scientific mindset. The final project scope will be defined with you.

Qualifications

• Enrolled in a Master's program in molecular biology or related field.
• Intern must be a formal, mandatory component of degree for graduation.
• Strong interest in immune-oncology and antibody biology.
• Basic molecular biology techniques including PCR, DNA cloning, mRNA production, and in vitro translation.
• Excellent analytical and problem-solving skills.
• Ability to work independently and as part of a team.
• Fluent in English (Genmab's primary language).

Responsibilities

• Assist in experimental design and execution, including optimization of display-related experiments.
• Learn molecular biology techniques such as PCR, mRNA production, cDNA synthesis, and in vitro translation.
• Collaborate with team to troubleshoot challenges and refine methods.
• Analyze experimental data and maintain detailed lab records.
• Present insights and troubleshoot at team meetings.

Skills

Molecular biology

PCR

mRNA production

cDNA synthesis

Team collaboration

English fluency

Education

Master's degree in molecular biology / biotechnology / immunology or related field

Tools

PCR equipment

DNA cloning

mRNA production tools

Job description

At Genmab, we are dedicated to building extra[not]ordinary futures, together, by developing antibody products and groundbreaking, knock-your-socks-off KYSO antibody medicines that change lives and the future of cancer treatment and serious diseases. We strive to create, champion and maintain a global workplace where individuals’ unique contributions are valued and drive innovative solutions to meet the needs of our patients, care partners, families and employees.

Our people are compassionate, candid, and purposeful, and our business is innovative and rooted in science. We believe that being proudly authentic and determined to be our best is essential to fulfilling our purpose. Yes, our work is incredibly serious and impactful, but we have big ambitions, bring a ton of care to pursuing them, and have a lot of fun while doing so.

Does this inspire you and feel like a fit? Then we would love to have you join us!

The Role

Join our Antibody Discovery and Lead Optimization team as an Intern, where you will get hands‑on experience across multiple disciplines. In this project you will be part of our Lead Optimization team, with the focus on establishing in vitro display technologies, which are powerful techniques used for the screening and identification of antibodies from large diverse libraries.

This internship will provide you with valuable insight and practical experience in molecular biology, protein engineering, and antibody discovery and will boost your scientific mindset and ultimately contribute to improving the lives of cancer patients!

The final project scope will be defined together with you

Responsibilities

• Assist in the design and execution of experiments, including optimizing mRNA and ribosome display for antibody screening.
• Learn and broaden your understanding of molecular biology techniques, such as PCR, mRNA production, cDNA synthesis, and in vitro translation.
• Collaborate with team members to troubleshoot experimental challenges and refine methodologies.
• Analyze and interpret experimental data while maintaining accurate and detailed laboratory records.
• Actively engage in team meetings by presenting insights and troubleshooting experimental challenges.

Requirements

• Currently enrolled in a Master’s degree program (in molecular biology, biotechnology, immunology, or related fields) connected to a local Dutch University.
• This internship must be a formal, mandatory component of your degree program required for graduation; we cannot consider candidates who have already graduated or who are seeking an extracurricular internship.
• A strong interest in immune-oncology and antibody biology, with an eagerness to learn new technologies.
• Basic knowledge of molecular biology techniques (e.g., PCR, DNA cloning, mRNA production, cDNA synthesis, in vitro translation).
• Excellent analytical, problem-solving, and detail-oriented skills.
• Ability to work independently and collaboratively and proactively managing your projects.
• High standards for quality and commitment to continuous improvement through feedback.
• Business fluent in English, Genmab's primary language.

General Internship Information

• Internship Duration: 7-10 months.
• Start date: preferably per 1 February 2027 (or 1 March 2027 - fixed start dates aligned with our internship cohorts, so you can join fellow students for onboarding and make the most of the shared learning activities throughout your internship).
• Location: Utrecht, Netherlands.
• Schedule: Full-time, onsite role.

The proposed gross annual/monthly base salary range for this position, in the primary location, based on a full time schedule is:

EUR750,00---750,00

The final salary offer will depend on several factors, including your skills, qualifications, and experience.

In addition to base salary, this position is eligible for additional forms of compensation, such as discretionary bonuses and long‑term incentives.

Benefits

• Pension
• Health insurance and wellness benefits
• Paid time off
• Employee support programs

Further details on eligibility for compensation and benefits based on the role will be provided during the recruitment process.

About Genmab

Genmab is an international biotechnology company with a core purpose to improve the lives of patients through innovative and differentiated antibody therapeutics. For 25 years, its hard‑working, innovative and collaborative team has invented next‑generation antibody technology platforms and harnessed translational, quantitative and data sciences, resulting in a proprietary pipeline including bispecific T‑cell engagers, antibody‑drug conjugates, next‑generation immune checkpoint modulators and effector function‑enhanced antibodies. By 2030, Genmab’s vision is to transform the lives of people with cancer and other serious diseases with Knock‑Your‑Socks‑Off (KYSO) antibody medicines.

Established in 1999, Genmab is headquartered in Copenhagen, Denmark with international presence across North America, Europe and Asia Pacific. For more information, please visit Genmab.com and follow us on LinkedIn and X.

Genmab is committed to protecting your personal data and privacy. Please see our privacy policy for handling your data in connection with your application on our website Job Applicant Privacy Notice (genmab.com).

Please note that if you are applying for a position in the Netherlands, Genmab’s policy for all permanently budgeted hires in NL is initially to offer a fixed‑term employment contract for a year, if the employee performs well and if the business conditions do not change, renewal for an indefinite term may be considered after the contract.